Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

58.59
Delayed Data
As of Aug 24
 -1.27 / -2.12%
Today’s Change
51.82
Today|||52-Week Range
77.12
-14.83%
Year-to-Date
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Spiros 'Sig' Segalas' Capital Appreciation Fund 2nd Quarter Commentary
Aug 18 / GuruFocus News - Paid Partner Content
Bristol-Myers Squibb Stock Will Bounce Back -- Here's How You Can Profit
Aug 22 / TheStreet.com - Paid Partner Content
Is It "Game Over" After Portola's FDA Rejection?
Aug 18 / MotleyFool.com - Paid Partner Content
These 3 Stocks Could Boost Their Dividends in the Next 12 Months
Aug 20 / MotleyFool.com - Paid Partner Content
What Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today
Aug 18 / MotleyFool.com - Paid Partner Content
Sporting goods leveling the field, which stocks say interest rates are going up: Jim ...
Aug 19 / TheStreet.com - Paid Partner Content
Why Portola Pharmaceuticals Inc Is Plunging Today
Aug 18 / MotleyFool.com - Paid Partner Content
This Could Be a Bottom for Bristol-Myers
Aug 19 / TheStreet.com - Paid Partner Content
Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close59.86
Today’s open59.80
Day’s range58.40 - 60.00
Volume13,198,695
Average volume (3 months)8,357,817
Market cap$100.0B
Dividend yield2.59%
Data as of 4:03pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+29.67%
Earnings growth (next 5 years)+20.20%
Revenue growth (last year)+4.29%
P/E ratio34.3
Price/Sales6.97
Price/Book6.97

Competitors

 Today’s
change
Today’s
% change
AGNAllergan-9.94-3.93%
SNYSanofi-0.38-0.97%
NVONovo Nordisk-0.53-1.12%
ABBVAbbVie-1.11-1.68%
Data as of 4:03pm ET, 08/24/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.64
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs